Klinique Medical Clinic Public Co. Ltd.

Klinique Medical Clinic Public Co. Ltd.

33.50
THB
+0.50
(+1.52%)
1.93EPS
13.90P/E
5.89BMarket Cap
Nov 12Next Earn
Klinique Medical Clinic Public Co. Ltd.
SET:KLINIQ
(Stock Exchange of Thailand)

Recent

price

33.50

P/E

ratio

13.90

div

yld

2.10%

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
THB
- -
6.22
5.94
9.66
10.39
13.52
16.13
18.71
Revenue per Share
- -
0.9
0.81
1.21
1.31
1.46
1.65
1.92
Basic EPS, GAAP
- -
0.62
1.03
1.07
0.09
-0.09
1.63
2.16
Free Cash Flow per Basic Share
- -
1.86
0.5
0.9
1.05
1.4
1.45
0.7
Dividend per Share
1.66
0.7
1
7.48
7.74
7.8
8.06
8.37
Book Value per Share
1.65
0.69
0.99
7.46
7.72
7.78
8.04
8.35
Tangible Book Value per Share
220
161
160
170
220
221
220
219
Basic Weighted Avg Shares
- -
1,001
950
1,639
2,285
2,983
3,556
4,105
Sales/Revenue/Turnover
- -
16.88
16.13
15.6
15.11
13.36
13.42
13.61
Operating Margin (%)
- -
77
81
142
195
282
333
361
Depreciation Expense
- -
145
129
205
289
322
364
422
Net Income, GAAP
- -
12.62
13.24
16.53
17.59
17.58
21.04
21.51
Effective Tax Rate (%)
- -
14.46
13.61
12.54
12.63
10.8
10.23
10.29
Profit Margin (%)
-158
-301
-296
972
711
279
218
258
Working Capital
5
149
149
234
371
530
530
484
LT Debt
266
111
161
1,646
1,703
1,717
1,781
1,849
Total Equity
- -
46.38
36.34
18.09
13.65
14.25
15.3
17.5
Return on Invested Capital (%)
- -
50.25
38.49
18.49
14.63
15.06
15.89
18.08
Return on Capital (%)
- -
76.74
95.13
22.75
17.24
18.84
20.84
23.6
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
147
158
163
LT Borrowings
- -
- -
- -
LT Finance Leases
530
497
484
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
220
220
220
Market Capitalization
4,708
5,170
5,885

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,238
1,453
1,370
Cash, Cash Equivalents & STI
717
927
811
Accounts Receivable, Net
12
13
16
Inventories
385
387
401
Total Current Liabilities
1,020
1,142
1,112
Payables & Accruals
387
457
401
ST Debt
147
158
163
Deferred Revenue
466
516
535

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
195.54%
3.75%
Free Cash Flow
- -
-410.62%
-1,827.73%
Net Income, GAAP
- -
22.65%
12.88%
Sales/Revenue/Turnover
- -
31.33%
19.22%
Total Cash Common Dividend
- -
21.18%
3.57%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
688
702
750
844
2,983
2025
814
851
878
1,014
3,556
2026
1,086
1,127
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.34
0.34
0.34
0.45
1.46
2025
0.39
0.41
0.36
0.5
1.65
2026
0.55
0.51
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.66
- -
1.4
2025
- -
- -
0.7
- -
1.45
2026
- -
- -
- -
- -
- -
Business
The Klinique Medical Clinic Public Company Limited (KLINIQ.BK) operates as a leading provider of aesthetic dermatology, plastic surgery, and holistic wellness services in Thailand. The company offers comprehensive skin medical treatments under the Klinique brand, including facelifts, acne and acne scar treatments, skin tightening, fillers, fat dissolving injections, laser hair removal, skin injections, mesoface and mesotherapy, rhinoplasty, eye surgery, and facial surgery; body and weight management programs; wellness therapies; and plastic surgery procedures through its dedicated departments. It also sells cosmetics and cosmeceuticals, with operations spanning approximately 43 branches nationwide, comprising 35 medical clinics, one surgery center, four laser centers, and three nail shops under brands such as THE KLINIQUE, THE KLINIQUE SURGERY CENTER, and L.A.B.X. Founded in 2009 and headquartered at No. 2922/296-299 Charn Issara Tower 2, 27th Floor, New Petchburi Road, Bang Kapi, Bangkok, Thailand, the company serves urban customers seeking advanced, patient-centered healthcare solutions with a focus on safety and innovative medical technologies. In recent developments, The Klinique Medical Clinic maintains steady expansion through its nationwide branch network while upholding leadership in cosmetic dermatology and preventive care megatrends, as evidenced by its operational footprint stable at 43 locations as of late 2022 data reflected in ongoing disclosures.